Resistance to type II JAK2 inhibition in MPN is dependent on MEK-ERK activation and is targetable Meeting Abstract
| Authors: | Codilupi, T.; Szybinski, J.; Wicki, A.; Yang, J. L.; Ghosh, N.; Passweg, J.; Tsakiris, D.; Levine, R. L.; Koche, R.; Meyer, S. C. |
| Abstract Title: | Resistance to type II JAK2 inhibition in MPN is dependent on MEK-ERK activation and is targetable |
| Meeting Title: | 2020 Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (DGHO) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 43 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Oct 9-11 |
| Meeting Location: | Virtual |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2020-10-01 |
| Start Page: | 81 |
| Language: | English |
| ACCESSION: | WOS:000575955000195 |
| PROVIDER: | wos |
| DOI: | 10.1159/000510995 |
| Notes: | Meeting Abstract: 449 -- "2020 Virtual Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
